GlassScriptPhysician profile
Amadi Rezai
NPI 1487602116
$4,056.14
in general payments reported to CMS, 2019-2025
32 companies · $588 in 2025
The $588 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $183 · 2021: $321 · 2022: $846 · 2023: $886 · 2024: $855 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $478.66 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $398.68 | 2023-2025 | Myfembree, Gemtesa |
| Daiichi Sankyo INC. | $388.79 | 2022-2024 | Injectafer |
| Astellas Pharma US INC | $372.44 | 2019-2025 | Veozah, Vesicare, Myrbetriq |
| Mayne Pharma Commercial LLC | $307.64 | 2022-2025 | |
| Exeltis, USA INC. | $285.77 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $282.23 | 2019-2025 | Fluent Fluid Management System, Aptima, Myosure Tissue Removal Device |
| Amgen INC. | $212.92 | 2019-2025 | Evenity, Prolia |
| Medtronic, INC. | $149.66 | 2021-2022 | |
| Sage Therapeutics, LLC | $127.97 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $127.36 | 2021-2022 | |
| Pfizer INC. | $126.02 | 2019-2024 | |
| Evofem Biosciences, INC. | $87.35 | 2022-2025 | Solosec, Phexx, Phexxi |
| Radius Health, INC. | $71.28 | 2022-2023 | |
| Lupin INC. | $70.35 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $61.18 | 2019-2021 | |
| Exact Sciences Corporation | $58.81 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $54.26 | 2019-2022 | |
| Organon LLC | $51.07 | 2023-2024 | Nexplanon |
| Amag Pharmaceuticals, INC. | $42.56 | 2019 | |
| Allergan, INC. | $37.44 | 2019-2020 | |
| Smith+Nephew, INC. | $36.55 | 2024 | Pico 7 |
| Bayer Healthcare Pharmaceuticals INC. | $33.22 | 2020-2025 | |
| Millicent US INC | $32.11 | 2020-2025 | Femlyv, Intrarosa |
| Agile Therapeutics, INC. | $29.11 | 2022-2023 | Twirla |
| Merck Sharp & Dohme LLC | $28.66 | 2019-2020 | |
| Avion Pharmaceuticals | $25.92 | 2021-2022 | |
| Menarini Silicon Biosystems, INC. | $24.21 | 2025 | Cellsearch |
| Si-Bone, INC. | $15.79 | 2021 | |
| Duchesnay USA Incorporated | $13.40 | 2019 | |
| Coopersurgical, INC. | $12.89 | 2021 | |
| Minerva Surgical, INC | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amadi Rezai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.